Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
09/24/1997 | EP0796847A1 Pyridine derivative, anti-ulcer drug, and antibacterial drug |
09/24/1997 | EP0796621A2 Preventing and treating periodontal disease |
09/24/1997 | EP0796257A1 Malonic acid based matrix metalloproteinase inhibitors |
09/24/1997 | EP0796249A1 Compounds for inhibition of gastric acid secretion |
09/24/1997 | EP0796243A1 Diaminocyclobutene-3,4-diones |
09/24/1997 | EP0696280B1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
09/24/1997 | CN1160401A Phenyl-oxo-alkyl-(4-piperidinyl) benzoate derivs. |
09/24/1997 | CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular. |
09/24/1997 | CN1160045A Matrix metalloprotease inhibitors |
09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
09/24/1997 | CN1159946A 冬莲强肝丸 Dong Lin Qianggan pill |
09/24/1997 | CN1159932A Powder for treating cholecystitis and preparing method thereof |
09/23/1997 | US5670630 Expression of hepatitis B S and preS2 proteins in methylotrophic |
09/23/1997 | US5670619 Bradykinin-antagonists for the treatment of acute pancreatitis |
09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
09/23/1997 | US5670522 Fused ring heterocycle, treatment of schizophrenia |
09/23/1997 | US5670516 Excitatory amino acid receptor antagonists |
09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
09/23/1997 | US5670499 Physiological disorders, gastrointestinal disorders, antiinflammatory agents |
09/23/1997 | US5670342 Stimulate the proliferation and differentiation of colon epithelial cells |
09/23/1997 | US5670158 Bisacodyl dosage form |
09/23/1997 | CA2045857C Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase a2 inhibitor containing them |
09/18/1997 | WO1997033885A1 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND DRUG COMPOSITIONS CONTAING THE DERIVATIVES |
09/18/1997 | WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
09/18/1997 | WO1997033877A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
09/18/1997 | WO1997033588A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
09/18/1997 | WO1997033573A1 Nasal administration of agents for treatment of delayed onset emesis |
09/18/1997 | WO1997033487A1 Oral composition for animals |
09/18/1997 | WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
09/18/1997 | CA2249011A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
09/18/1997 | CA2248964A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
09/17/1997 | EP0795604A2 Strains of bacteria with altered metabolism of bile acids and their use |
09/17/1997 | EP0795025A1 Enantioselective preparation of pharmaceutically active sulfoxides by bioreduction |
09/17/1997 | EP0795024A1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation |
09/17/1997 | EP0794956A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
09/17/1997 | EP0794951A1 Processes and intermediates for preparing cis(+)3- 4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
09/17/1997 | EP0794944A1 Perhydroisoindole derivatives as antagonists of substance p |
09/17/1997 | EP0794942A1 Substituted biphenyl compounds for the treatment of inflammation |
09/17/1997 | EP0794939A1 Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods of preparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions |
09/17/1997 | EP0794938A1 Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy |
09/17/1997 | EP0794799A2 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography |
09/17/1997 | EP0794790A1 Localized delivery of factors enhancing survival of transplanted cells |
09/17/1997 | EP0794788A1 Hepatic-directed compounds and reagents for preparation thereof |
09/17/1997 | EP0525123B1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
09/17/1997 | CN1159806A Imidazopyridine-pyrrolidone and imidazopyridine-oxaolidone |
09/17/1997 | CN1159804A Dihydrobenzofuranes |
09/17/1997 | CN1159797A Aryloxy and arylthiopropanolamine derivative suseful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
09/17/1997 | CN1159444A Sulfuryl amino substituted benzoyl guanidine, preparation process and applications as medicine or diagnostic agent and the medicine containing same |
09/16/1997 | US5668279 Treatment of central nervous system diorders and gastrointestinal disorders |
09/16/1997 | US5668139 Xanthine derivatives |
09/16/1997 | US5668137 N-heterocyclic sulfonamides having endothelin receptor activity |
09/16/1997 | US5668130 Medicament for treating gastrointestinal disorders |
09/16/1997 | US5668129 N-substituted azaheterocyclic carboxylic acids and esters thereof |
09/16/1997 | US5668126 Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
09/16/1997 | US5668123 Method of maintaining remission from venous ulcers with sulphasalazine and its metabolite |
09/16/1997 | US5668109 Peptides for inhibiting pepsin release |
09/16/1997 | CA2170250C Preparation of omeprazole and lansoprazole and intermediates useful therein |
09/16/1997 | CA2166483C New pharmaceutical formulation |
09/16/1997 | CA2000464C Dentifrice compositions |
09/16/1997 | CA1339464C ¬leu13| motilin, dnas coding for same and methods for producing same |
09/12/1997 | WO1997032870A1 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
09/12/1997 | WO1997032865A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
09/12/1997 | WO1997032846A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
09/12/1997 | WO1997032582A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
09/12/1997 | WO1997032576A1 Use of aryl n-substituted carboxamides to kill tumors |
09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
09/12/1997 | WO1997032565A1 Anti-caries oral compositions |
09/12/1997 | WO1997021416A3 Glycoconjugates of opiated substances |
09/12/1997 | CA2248125A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
09/12/1997 | CA2248109A1 Use of aryl n-substituted carboxamides to kill tumors |
09/11/1997 | DE19608665A1 Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Arylglycinamidderivate, processes for their preparation containing these compounds and pharmaceutical compositions |
09/10/1997 | EP0793665A1 Heterocyclic compounds and their preparation and use |
09/10/1997 | EP0793660A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
09/10/1997 | EP0793643A1 Matrix metalloprotease inhibitors |
09/10/1997 | EP0793641A1 Metalloproteinase inhibitors |
09/10/1997 | EP0793503A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
09/10/1997 | EP0793495A1 Freeze-dried ondansetron compositions |
09/10/1997 | EP0712403B1 Matrix metalloprotease inhibitors |
09/10/1997 | EP0675724B1 Use of dideoxy nucleoside analogues in the treatment of viral infections |
09/10/1997 | EP0644767B1 Veterinary rehydration product |
09/10/1997 | EP0558635B1 Improved matrix metalloprotease inhibitors |
09/10/1997 | EP0544886B1 METHOD OF EXTRACTING SENNOSIDES A, B and A1 |
09/10/1997 | EP0466833B1 Protease inhibitor |
09/10/1997 | CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
09/10/1997 | CN1158729A Medicine powder for hepatitis B and its prepn |
09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
09/10/1997 | CN1035801C Microgranular preparation useful in delivery of biologically active materials to intestinal regious of animals |
09/09/1997 | US5665883 Treatment of pain, inflammation, migraine, emesis |
09/09/1997 | US5665767 Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same |
09/09/1997 | US5665758 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
09/09/1997 | US5665745 1,2,5-thiadiazole derivatives for treating diseases of central nervous system |
09/09/1997 | US5665743 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
09/09/1997 | US5665730 Pharmaceutically useful imidazopyridines |
09/09/1997 | US5665566 Cloning of enterokinase and method of use |
09/09/1997 | US5665352 Process for reducing the extent of cryptosporidium diarrhoeas |
09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
09/04/1997 | WO1997031923A1 Proton pump inhibitor |
09/04/1997 | WO1997031897A1 Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
09/04/1997 | WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |